ResearcherKagoshima UniversityActive in the last 2 years
Akihide Tanimoto
Matched on ORCID iD 0000-0001-7508-1624; OpenAlex author ID A5037769750. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 19
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 4
- Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002373↗
- Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prosp… First author DOI 10.3390/diagnostics13061078↗
- Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic ca… Last author DOI 10.1002/dc.25022↗
- Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning. Last author DOI 10.1158/1078-0432.ccr-19-1247↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michiyo Higashi · 4 shared papers, 2020–2024 · strength 0.59
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-b… DOI 10.1002/dc.25022↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Takao Ohtsuka · 3 shared papers, 2022–2024 · strength 0.49
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-b… DOI 10.1002/dc.25022↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Shinichi Hashimoto · 2 shared papers, 2022–2023 · strength 0.30
- Paper Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-b… DOI 10.1002/dc.25022↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Hiromichi Iwaya · 2 shared papers, 2022–2023 · strength 0.30
- Paper Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-b… DOI 10.1002/dc.25022↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Akio Ido · 2 shared papers, 2022–2023 · strength 0.30
- Paper Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-b… DOI 10.1002/dc.25022↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Hiroshi Kurahara · 2 shared papers, 2020–2024 · strength 0.28
- Seiya Yokoyama · 2 shared papers, 2020–2022 · strength 0.25
- Tetsuya Idichi · 1 shared paper, 2024 · strength 0.19
- Yuto Hozaka · 1 shared paper, 2024 · strength 0.19
- Yuko Mataki · 1 shared paper, 2024 · strength 0.19
- Kosuke Fukuda · 1 shared paper, 2024 · strength 0.19
- Hideyuki Oi · 1 shared paper, 2024 · strength 0.19
- Shiho Arima · 1 shared paper, 2023 · strength 0.15
- Makoto Hinokuchi · 1 shared paper, 2023 · strength 0.15
- Suguru Yonezawa · 1 shared paper, 2020 · strength 0.09
- Kosei Maemura · 1 shared paper, 2020 · strength 0.09
- Michael Anthony Hollingsworth · 1 shared paper, 2020 · strength 0.09
- Surinder K. Batra · 1 shared paper, 2020 · strength 0.09
- Marko Kornmann · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.